Belgium· BE-AMP-SAM226457-00
Renagel 800 mg
A sevelamer product containing sevelamer hydrochloride, registered in Belgium by Sanofi. The same ATC class is registered in 18 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Sevelamer is registered in 18 of 19 countries.
Countries holding a registration under ATC V03AE02 (sevelamer), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 11 of them publish a price we can compare per daily dose
Sevelamer · ATC V03AE02
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of sevelamer costs, country by country.
Normalised to the WHO defined daily dose (6.4 g), the median price runs from $3.42 in France to $9.10 in Switzerland — a ×2.7 gap.
- 5 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Sevelamer · price per daily dose (6.4 g)
USD · FX 28 Sept 2026
- CH Switzerland$9.10
- ES Spain$6.97
- IT Italy$5.92
- US United States$5.56 (acquisition cost)
- FR France$3.42
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Sevelamer Hydrochloride
- Manufacturer
- Sanofi
- Country
- Belgium (BE)
- ATC code
- V03AE02
- ATC class
- Sevelamer
- Defined daily dose
- 6.4 g, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb1770502
- be_apb0773044
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
293 interactions on record for sevelamer.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Sevelamer · interactions on record
293 records
- 2 severe
- 31 moderate
- 258 info
Most severe, free to view
- ErdafitinibL01EN01severe
- ErdafitinibL01EX16severe
- ErgocalciferolA11CC01moderate
- DihydrotachysterolA11CC02moderate
2 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Sevelamer in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United Statessevelamer hydrochlorideNorthStar RxLLC
- CzechiaRENAGELSanofi Winthrop Industrie, Gentilly
- FinlandRenagelOy Cross Pharma Ab
- IrelandSevelamer Hydrochloride Waymade 800 mg film-coated tabletsWaymade B.V.
- SwedenRenagel 800 mg Filmdragerad tablettSanofi Winthrop Industrie
- GermanySevelamerhydrochlorid WaymadeWaymade B.V.
- CanadaRENAGELSANOFI-AVENTIS CANADA INC
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Germany · Sevelamerhydrochlorid Waymade
- Denmark · Sevelamerhydrochlorid Waymade
- Spain · Hidrocloruro De Sevelámero Waymade
- France · Chlorhydrate De Sevelamer Waymade
- United Kingdom (Northern Ireland) · Sevelamer Hydrochloride Waymade
- Greece · Υδροχλωρικη Σεβελαμερη Waymade
- Ireland · Sevelamer Hydrochloride Waymade
- Iceland · Renagel
- Italy · Sevelamer Waymade
- Liechtenstein · Renagel
- Netherlands · Sevelameerhydrochloride Waymade
- Norway · Renagel
- Romania · Clorhidrat De Sevelamer Waymade
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/92a8f65d-8f1a-4f23-91ac-8019b832d3c5 GET /v1/drugs/92a8f65d-8f1a-4f23-91ac-8019b832d3c5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Renagel 800 mg",
"name_fr": "Renagel 800 mg",
"name_nl": "Renagel 800 mg",
"amp_code": "SAM226457-00",
"strengths": [
"800.0000",
"800.0000",
"800.0000"
],
"pack_count": 6,
"substances": [
"Sevelamer Hydrochloride",
"Propylene Glycol"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Sevelamer",
"authorisation_numbers": [
"EU/1/99/123/008",
"EU/1/99/123/009",
"EU/1/99/123/010",
"EU/1/99/123/011",
"EU/1/99/123/012",
"EU/1/99/123/013"
]
}See everything about sevelamer.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.